Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 41, Issue 3, Pages 686-694
Publisher
Springer Nature
Online
2015-06-24
DOI
10.1038/npp.2015.188
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism
- (2015) Samantha J Podurgiel et al. NEUROPSYCHOPHARMACOLOGY
- Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists
- (2015) Marta Pardo et al. PSYCHOPHARMACOLOGY
- Bupropion Increases Selection of High Effort Activity in Rats Tested on a Progressive Ratio/Chow Feeding Choice Procedure: Implications for Treatment of Effort-Related Motivational Symptoms
- (2015) P. A. Randall et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Depression, Stress, and Anhedonia: Toward a Synthesis and Integrated Model
- (2014) Diego A. Pizzagalli Annual Review of Clinical Psychology
- Dopamine Antagonism Decreases Willingness to Expend Physical, But Not Cognitive, Effort: A Comparison of Two Rodent Cost/Benefit Decision-Making Tasks
- (2014) Jay G Hosking et al. NEUROPSYCHOPHARMACOLOGY
- The VMAT-2 Inhibitor Tetrabenazine Affects Effort-Related Decision Making in a Progressive Ratio/Chow Feeding Choice Task: Reversal with Antidepressant Drugs
- (2014) Patrick A. Randall et al. PLoS One
- The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion
- (2014) Samantha E. Yohn et al. PSYCHOPHARMACOLOGY
- Toward the future of psychiatric diagnosis: the seven pillars of RDoC
- (2013) Bruce N Cuthbert et al. BMC Medicine
- The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorder
- (2013) Anthony J. Rothschild et al. COMPREHENSIVE PSYCHIATRY
- CLINICAL RELEVANCE OF FATIGUE AS A RESIDUAL SYMPTOM IN MAJOR DEPRESSIVE DISORDER
- (2013) Maurizio Fava et al. DEPRESSION AND ANXIETY
- Effort-Related Motivational Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Animal Models of the Motivational Symptoms of Depression
- (2013) E. J. Nunes et al. JOURNAL OF NEUROSCIENCE
- Resolution of sleepiness and fatigue: A comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union
- (2013) James A Cooper et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Invigoration of Reward Seeking by Cue and Proximity Encoding in the Nucleus Accumbens
- (2013) Vincent B. McGinty et al. NEURON
- Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task
- (2013) Eric J. Nunes et al. PSYCHOPHARMACOLOGY
- Reversal of SSRI-Associated Apathy Syndrome by Discontinuation of Therapy
- (2012) Prasad R Padala et al. ANNALS OF PHARMACOTHERAPY
- Effect of GBR12909 on affective behavior: Distinguishing motivational behavior from antidepressant-like and addiction-like behavior using the runway model of intracranial self-stimulation
- (2012) Satoru Esumi et al. BEHAVIOURAL BRAIN RESEARCH
- Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex
- (2012) Alan L. Hudson et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature
- (2012) Jack J. Chen et al. CLINICAL THERAPEUTICS
- Increased monoaminergic neurotransmission improves compliance with physical activity recommendations in depressed patients with fatigue
- (2012) Emelie Stenman et al. MEDICAL HYPOTHESES
- The Mysterious Motivational Functions of Mesolimbic Dopamine
- (2012) John D. Salamone et al. NEURON
- Acute Stress Induces Selective Alterations in Cost/Benefit Decision-Making
- (2012) Naghmeh Shafiei et al. NEUROPSYCHOPHARMACOLOGY
- Dopaminergic Modulation of Effort-Related Choice Behavior as Assessed by a Progressive Ratio Chow Feeding Choice Task: Pharmacological Studies and the Role of Individual Differences
- (2012) Patrick A. Randall et al. PLoS One
- Motivational states influence effort-based decision making in rats: The role of dopamine in the nucleus accumbens
- (2011) Bettina Mai et al. COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE
- Tetrabenazine is neuroprotective in Huntington's disease mice
- (2010) Hongyu Wang et al. Molecular Neurodegeneration
- Reconsidering anhedonia in depression: Lessons from translational neuroscience
- (2010) Michael T. Treadway et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The role of serotonin receptor subtypes in treating depression: a review of animal studies
- (2010) Gregory V. Carr et al. PSYCHOPHARMACOLOGY
- Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
- (2010) Samuel Frank Neuropsychiatric Disease and Treatment
- Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report
- (2009) A. A. Nierenberg et al. PSYCHOLOGICAL MEDICINE
- The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure
- (2009) Allison M. Mott et al. PSYCHOPHARMACOLOGY
- Effects of fluoxetine on the rat brain in the forced swimming test: A [F-18]FDG micro-PET imaging study
- (2008) Dong-Pyo Jang et al. NEUROSCIENCE LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More